Zenas Biopharma Inc (ZBIO)

09:08 AM

ENAVATE SCIENCES GP, LLC Expands Stake in Zenas BioPharma Inc - GuruFocus

09:08 AM

03:56 AM

Strategies to average down on Zenas BioPharma Inc.2025 Top Gainers & Daily Price Action Insights - newser.com

03:56 AM

11:11 AM

Will Zenas BioPharma Inc. stock benefit from AI adoptionEarnings Risk Summary & Community Shared Stock Ideas - Trung tâm Dự báo KTTV quốc gia

11:11 AM

10:34 AM

Is Zenas BioPharma Inc a good long term investmentRisk-Reward Ratio Analysis & Maximum Profit Growth - earlytimes.in

10:34 AM

08:45 AM

Insiders Bet Big on These 3 Fintech and Biotech Stocks - 24/7 Wall St.

08:45 AM

01:22 AM

How Zenas BioPharma Inc. stock reacts to inflationary pressuresOil Prices & Low Drawdown Investment Strategies - newser.com

01:22 AM

Oct 16, 2025

Chairman and CEO of Zenas BioPharma (ZBIO) Buys 36,928 Shares for $769,948 - The Motley Fool

Oct 16, 2025

Oct 15, 2025

InnoCare licensing deal flops due to lack of upfront cash - thebambooworks.com

Oct 15, 2025

Oct 15, 2025

What to expect from Zenas BioPharma Inc. in the next 30 daysJuly 2025 Intraday Action & Daily Volume Surge Signals - newser.com

Oct 15, 2025

Oct 15, 2025

Should you wait for a breakout in Zenas BioPharma Inc.July 2025 Fed Impact & Verified Momentum Watchlists - newser.com

Oct 15, 2025

Oct 14, 2025

Major Stakeholders Make Bold Moves in Zenas BioPharma Stock! - TipRanks

Oct 14, 2025

Oct 14, 2025

Nunn Jason Raleigh buys Zenas Biopharma (ZBIO) shares worth $1.2 million - Investing.com Nigeria

Oct 14, 2025

Oct 14, 2025

Sr One Capital buys Zenas Biopharma (ZBIO) shares worth $2.4 million By Investing.com - Investing.com South Africa

Oct 14, 2025

Oct 14, 2025

Sr One Capital buys Zenas Biopharma (ZBIO) shares worth $2.4 million - Investing.com

Oct 14, 2025

Oct 14, 2025

Risk vs reward if holding onto Zenas BioPharma Inc.Market Performance Summary & Low Risk Investment Opportunities - newser.com

Oct 14, 2025

Oct 14, 2025

Zenas BioPharma rises after Wedbush raises price target - MSN

Oct 14, 2025

Oct 14, 2025

Zenas gets global rights for Innocare BTK inhibitor in $2B+ deal - BioWorld MedTech

Oct 14, 2025

Oct 14, 2025

Enright buys Zenas Biopharma (ZBIO) stock worth $2.25 million By Investing.com - Investing.com Nigeria

Oct 14, 2025

Oct 14, 2025

Enright buys Zenas Biopharma (ZBIO) stock worth $2.25 million - Investing.com

Oct 14, 2025

Oct 14, 2025

Zenas climbs on licensing deal with InnoCare - MSN

Oct 14, 2025

Oct 13, 2025

How to build a dashboard for Zenas BioPharma Inc. stockPortfolio Gains Report & Safe Swing Trade Setups - newser.com

Oct 13, 2025

Oct 12, 2025

Zenas BioPharma, Inc. (ZBIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Oct 12, 2025

Oct 12, 2025

Zenas BioPharma Independent Director Acquires 447% More Stock - simplywall.st

Oct 12, 2025

Oct 11, 2025

Zenas BioPharma (ZBIO): Assessing Valuation Following $2B InnoCare Deal and Pipeline Expansion - Sahm

Oct 11, 2025

Oct 10, 2025

Zenas Biopharma stock hits all-time high at 29.29 USD By Investing.com - Investing.com Canada

Oct 10, 2025

Oct 10, 2025

Insider Buying: Zenas BioPharma (NASDAQ:ZBIO) Insider Buys 36,928 Shares of Stock - MarketBeat

Oct 10, 2025

Oct 10, 2025

Zenas BioPharma (NASDAQ:ZBIO) Director Hongbo Lu Purchases 263,160 Shares - MarketBeat

Oct 10, 2025

Oct 10, 2025

Fairmount Funds Management Llc Acquires 316,219 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock - MarketBeat

Oct 10, 2025

Oct 10, 2025

Zenas Biopharma stock hits all-time high at 29.29 USD - Investing.com India

Oct 10, 2025

Oct 10, 2025

Hedge Fund and Insider Trading News: Jeffrey Ubben, Ken Griffin, Chris Hohn, Bill Ackman, Scott Bessent, Alden Global Capital, Balyasny Asset Management, Eisler Capital, Zenas Biopharma Inc (ZBIO), Dell Technologies Inc (DELL), and More - Insider Monkey

Oct 10, 2025

Oct 10, 2025

Zenas BioPharma (ZBIO) Is Up 32.5% After Securing Global Rights to Orelabrutinib in MS Deal - Yahoo Finance

Oct 10, 2025

Oct 10, 2025

Zenas BioPharma (NASDAQ:ZBIO) Sets New 1-Year High Following Analyst Upgrade - MarketBeat

Oct 10, 2025

Oct 10, 2025

Zenas BioPharma Inc Stock Analysis and ForecastSector Rotation Strategies & Watch Expert Picks Before They Rally - earlytimes.in

Oct 10, 2025

Oct 10, 2025

Will Zenas BioPharma Inc. stock go up soonTrade Entry Summary & Scalable Portfolio Growth Ideas - newser.com

Oct 10, 2025

Oct 10, 2025

Wedbush Issues Positive Forecast for Zenas BioPharma (NASDAQ:ZBIO) Stock Price - MarketBeat

Oct 10, 2025

Oct 10, 2025

HC Wainwright Reiterates Buy Rating for Zenas BioPharma (NASDAQ:ZBIO) - MarketBeat

Oct 10, 2025

Oct 10, 2025

Zenas BioPharma files automatic mixed securities shelf - MSN

Oct 10, 2025

Oct 10, 2025

Zenas BioPharma: Strategic Licensing and Clinical Advancements Justify Buy Rating - TipRanks

Oct 10, 2025

Oct 10, 2025

Rx Rundown: Novo Nordisk, Chiesi Group, Zenas Biopharma and more - Medical Marketing and Media

Oct 10, 2025

Oct 10, 2025

Zenas Biopharma (ZBIO) director Moulder buys $770k in shares By Investing.com - Investing.com South Africa

Oct 10, 2025

Oct 10, 2025

InnoCare Pharma: Obutinib signs licensing agreement with Zenas BioPharma - iHeart

Oct 10, 2025

Oct 09, 2025

Insider Buying Spree: Zenas BioPharma Executives Make Bold Moves! - TipRanks

Oct 09, 2025

Oct 09, 2025

Zenas Biopharma (ZBIO) director Moulder buys $770k in shares - Investing.com

Oct 09, 2025